![Joshua Brumm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joshua Brumm
Plus aucun poste en cours
Fortune : 4 M $ au 31/07/2026
Profil
Joshua T.
Brumm was the founder of Water Street Solutions, Inc. since 2002, holding the title of Chief Executive Officer from 2002 to 2007.
Current jobs include Chief Executive Officer & Director at Crescent Biopharma, Inc. since 2025, Chairman at Amphista Therapeutics Ltd. since 2021, Advisor at Atlas Venture Advisors, Inc., and General Partner at Forbion Capital Partners Management Holding BV since 2024.
Former jobs include Chief Executive Officer & Director at Crescent Biopharma, Inc. (Old), President, CEO, Secretary & Director at Dyne Therapeutics, Inc. from 2019 to 2024, Finance Director at Proteolix, Inc. in 2009, Executive VP, Chief Financial & Accounting Officer at Pharmacyclics LLC from 2012 to 2013, CFO, Senior VP & Head-Investor Relations at ZELTIQ Aesthetics, Inc. in 2012, Chief Operating & Financial Officer at Versartis, Inc. in 2017, Chief Operating & Financial Officer at Kaleido Biosciences, Inc. from 2018 to 2019, and COO & CFO at Aravive, Inc. from 2013 to 2017.
Education includes an undergraduate degree from the University of Notre Dame, conferred in 2004.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,76% | 22/06/2026 | 281 212 ( 0,76% ) | 4 M $ | 31/07/2026 |
Postes actifs de Joshua Brumm
| Sociétés | Poste | Début |
|---|---|---|
Amphista Therapeutics Ltd.
 Amphista Therapeutics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Président | 21/09/2021 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Private Equity Investor | 01/06/2024 |
Anciens postes connus de Joshua Brumm
| Sociétés | Poste | Fin |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Directeur Général | 25/03/2024 |
| KALEIDO BIOSCIENCES, INC. | Directeur Financier/CFO | 11/10/2019 |
| ARAVIVE, INC. | Directeur Financier/CFO | 31/12/2017 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Directeur Financier/CFO | 01/12/2017 |
| PHARMACYCLICS, INC. | Directeur Financier/CFO | 14/08/2013 |
Formation de Joshua Brumm
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ZELTIQ Aesthetics, Inc.
 ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops non-invasive procedures for the reduction of unwanted fat tissue | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Water Street Solutions, Inc.
 Water Street Solutions, Inc. Water UtilitiesUtilities Provides industrial water and wastewater treatment systems and services | Utilities |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Aravive, Inc.
 Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Amphista Therapeutics Ltd.
Amphista Therapeutics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
